Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. for CNY 190 million on March 21, 2024.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.61 CNY | -0.30% | -4.20% | -13.14% |
1st Jan change | Capi. | |
---|---|---|
-13.14% | 472M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 600613 Stock
- News Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
- Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd. for CNY 190 million.